In addition, Scientific Industries has engaged the seller to perform research and development services with respect to bioprocessing products and has entered into a non-competition agreement with seller’s affiliates.
Scientific Industries president and CEO Helena R Santos said the acquisition of licenses reflects a product line diversification with considerable growth potential.
Scientific Industries’ products are generally used for research purposes in laboratories of universities, hospitals, pharmaceutical companies, chemical companies and medical device manufacturers.